Jill U. Adams is a freelance science journalist based in Albany, New York. She covers health, mental health and biomedical research for such publications as The Transmitter, The Washington Post, Scientific American, Undark and The Scientist. She has a Ph.D. in pharmacology from Emory University in Atlanta, Georgia.
Jill Adams
Contributing writer
From this contributor
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
FDA website no longer warns against bogus autism therapies, and more
By
Jill Adams
27 January 2026 | 2 min read
Sensory profiles in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 January.
Alzheimer’s disease and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 12 January.
Profiles of neurodevelopmental conditions; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 5 January.
Profiles of neurodevelopmental conditions; and more
By
Jill Adams
6 January 2026 | 1 min read
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
Explore more from The Transmitter
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
By
Siddhant Pusdekar
27 January 2026 | 5 min read